U.S. markets close in 1 hour 49 minutes
  • S&P 500

    4,544.27
    -5.51 (-0.12%)
     
  • Dow 30

    35,681.80
    +78.72 (+0.22%)
     
  • Nasdaq

    15,085.65
    -130.05 (-0.85%)
     
  • Russell 2000

    2,289.58
    -6.60 (-0.29%)
     
  • Crude Oil

    83.52
    +1.02 (+1.24%)
     
  • Gold

    1,793.00
    +11.10 (+0.62%)
     
  • Silver

    24.36
    +0.19 (+0.81%)
     
  • EUR/USD

    1.1640
    +0.0009 (+0.08%)
     
  • 10-Yr Bond

    1.6590
    -0.0170 (-1.01%)
     
  • GBP/USD

    1.3742
    -0.0054 (-0.39%)
     
  • USD/JPY

    113.5030
    -0.4850 (-0.43%)
     
  • BTC-USD

    60,670.88
    -2,382.91 (-3.78%)
     
  • CMC Crypto 200

    1,445.24
    -57.79 (-3.85%)
     
  • FTSE 100

    7,204.55
    +14.25 (+0.20%)
     
  • Nikkei 225

    28,804.85
    +96.27 (+0.34%)
     

InterCure to Present in Benzinga Cannabis Capital Conference

  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

NEW YORK and TORONTO and HERZLIYA, Israel, Oct. 13, 2021 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) today announced that Alexander Rabinovitch, CEO of InterCure, will present at the Benzinga Cannabis Capital Conference on Thursday, October 14, 2021 at 1:50pm ET. The presentation will be shown again on October 15th at 1:50pm ET. In addition, Mr. Rabinovitch will participate in a live panel discussion titled, “International Spotlight – Continued Cannabis Expansion in European Markets” on Friday, October 15 at 2:10pm ET. To view the Company presentation, please click the following link: https://youtu.be/8JtjK9-IW80. To watch the live panel discussion, please click the following link: https://youtu.be/9gEdUHA8T0g.

Management will be available for virtual one-on-one meetings with registered conference attendees. To register for the conference, please visit the conference website: https://www.benzinga.com/events/cannabis/october-2021/#who-attends

If you are interested in scheduling a one-on-one meeting with InterCure’s management team, please contact InterCure@kcsa.com.

About InterCure (dba Canndoc)

InterCure (dba Canndoc) (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) is the leading, profitable, and fastest growing cannabis company outside of North America. Canndoc, a wholly owned subsidiary of InterCure, is Israel’s largest licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products. InterCure leverages its market leading distribution network, best in class international partnerships and a high-margin vertically integrated "seed-to-sale" model to lead the fastest growing cannabis global market outside of North America.

For more information, visit: http://www.intercure.co.

To be added to InterCure’s email distribution list, please email InterCure@kcsa.com with “InterCure” in the subject.

Contact:

InterCure Ltd.
Amos Cohen, Chief Financial Officer
amos@canndoc-pharma.com

KCSA Strategic Communications
Investor and Media Relations
InterCure@kcsa.com